BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced an updated timeline for submitting its Biologics ...

Larimar: Stronger Buy Now More Than Ever After Partial Clinical Hold Completely Removed. May 31, 2024 4:11 PM ET Larimar Therapeutics, Inc. (LRMR) Stock BIIB, DSGN, LXEO, PTCT, LRMR 5 Comments.

Larimar Therapeutics. Open label extension (OLE) study is progressing with all 7 sites activated; interim data planned for Q4 2024. Selected by Food and Drug Administration (FDA) to participate in ...

Now, the 45-year-old singer-songwriter has a Latin Grammy on his shelf for his 2020 album “Larimar.” “I have always been in love with the stone,” he said in a video interview.

Larimar Therapeutics LRMR is a clinical-stage company making medicines for rare diseases. The company has a Zacks Rank #1 (Strong Buy). Here we discuss some reasons why investing in LRMR stock now ...

Larimar can now give patients 50 mg doses in longer studies. March 2025 Update. Larimar reported a case of anaphylaxis in its long-term OLE study. The reaction resolved with treatment, ...

That’s now been completed, and Larimar is free to proceed with the 50-mg cohort in the open-label extension. CEO Carole Ben-Maimon, M.D., said work will get underway after “further ...

With a strong financial position of $203.7 million in cash and investments as of September 30, 2024, Larimar is well-positioned to advance nomlabofusp toward commercialization while fostering hope ...

Larimar Therapeutics LRMR is a clinical-stage company making medicines for rare diseases. The company has a Zacks Rank #1 (Strong Buy). Here we discuss some reasons why investing in LRMR stock now is ...